Cabergoline: a review of its use in the inhibition of lactation for women living with HIV.
CONCLUSIONS: Cabergoline is a safe and effective pharmacologic option for the prevention of physiological lactation and associated physical symptoms in non-breastfeeding women. Future studies should focus on its safety, efficacy and acceptability among WLWH.
PMID: 31183987 [PubMed - in process]
Source: Journal of the International AIDS Society - Category: Infectious Diseases Tags: J Int AIDS Soc Source Type: research
More News: Breastfed | Clinical Trials | Estradiol | HIV AIDS | Infectious Diseases | Science | Study | Women